Clinical Trials Directory

Trials / Conditions / Relapse/Refractory Multiple Myeloma

Relapse/Refractory Multiple Myeloma

7 registered clinical trials studyying Relapse/Refractory Multiple Myeloma — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study of DeepTag-GPRC5D Targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple Myeloma
NCT06084962
He HuangPhase 1
Active Not RecruitingSafety, Activity and Cell Kinetics of CYAD-211 in Patients With Relapsed or Refractory Multiple Myeloma
NCT04613557
Celyad Oncology SAPhase 1
CompletedA Study of Evaluating the Safety and Efficacy of ATG-010 in Relapsed Refractory Multiple Myeloma
NCT03944057
Antengene CorporationPhase 2
CompletedRetrospective and Prospective Study of POmalidomide Plus LoW Dose Dexa Efficacy in RRMM Patients Under Real-Li
NCT03353545
Genesis Pharma S.A.—
WithdrawnClarithromycin,Lenalidomide and Dexamethasone for Relapsed/Refractory Myeloma
NCT02986451
Sun Yat-sen UniversityPhase 2
CompletedStudy of Panobinostat in Combination With Bortezomib and Dexamethasone in Japanese Patients With Relapsed/Refr
NCT02290431
Novartis PharmaceuticalsPhase 2
WithdrawnPaclitaxel,Cyclophosphamide and Dexamethasone for Relapsed or Refractory Multiple Myeloma
NCT02985333
Sun Yat-sen UniversityPhase 2